Cellular Biomedicine Group

22Sep

CBMG Plans Grand Opening of its New Shanghai Facility

14Sep

CBMG To Present At The Cantor Fitzgerald Global Healthcare Conference

8Aug

Second Quarter and First Half 2017 Financial Results and Business Highlights

26Jun

Appointment of Dr. Xia Meng as Chief Operating Officer to Lead Commercialization of the Company’s CAR-T and Stem Cell Products

20Jun

Appointment of Michael A. Caligiuri, MD as Chair of External Advisory Board

1Jun

CBMG Announces Stock Repurchase Program

19May

Publication of Abstract at ASCO 2017

15May

Addition of a Second Clinical Site in the Expansion of its Chimeric Antigen Receptor T-cell (CAR-T) Phase I Clinical Trial for Its CARD-1 Trial

8May

First Quarter 2017 Financial Results and Business Highlights

1May

Results of 2017 Annual Meeting of Stockholders